Dongyi Du
Biographic Data
| ID | 5541957 |
|---|---|
| NAME | Dongyi Du |
| GIVEN NAMES | Dongyi |
| FAMILY NAME | Du |
| SIGNATURE | DU D |
| AFFILIATIONS | University of Maryland, Baltimore |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 2 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2009 |
| LATEST PUBLICATION YEAR | 2012 |
| H-INDEX | 1 |
Atomoxetine Use During a Period of FDA Actions
CONTEXT: The Food and Drug Administration (FDA) issued a Public Health Advisory entitled "Suicidal Thinking in Children and Adolescents Being Treated with Strattera (Atomoxetine)" on September 29, 2005. At FDA's request, the manufacturer subsequently added a boxed warning to the drug's labeling on November 8, 2005. OBJECTIVE: To evaluate whether the boxed warning for suicidal thinking in atomoxetine's labeling was associated with a change in the …
Recent Improvements in Bariatric Surgery Outcomes
OBJECTIVE: Bariatric surgery is one of the fastest growing hospital procedures, but with a 40% complication rate in 2001. Between 2001 and 2005 bariatric surgeries grew by 113%. Our objective is to examine how 6-month complications improved between 2001 and 2006, using a nationwide, population-based sample. DATA/DESIGN: We examined insurance claims in 2001-2002 and 2005-2006 for 9582 bariatric surgeries, at 652 hospitals, among a population of 16…
Atomoxetine Use During a Period of FDA Actions
CONTEXT: The Food and Drug Administration (FDA) issued a Public Health Advisory entitled "Suicidal Thinking in Children and Adolescents Being Treated with Strattera (Atomoxetine)" on September 29, 2005. At FDA's request, the manufacturer subsequently added a boxed warning to the drug's labeling on November 8, 2005. OBJECTIVE: To evaluate whether the boxed warning for suicidal thinking in atomoxetine's labeling was associated with a change in the …
Recent Improvements in Bariatric Surgery Outcomes
OBJECTIVE: Bariatric surgery is one of the fastest growing hospital procedures, but with a 40% complication rate in 2001. Between 2001 and 2005 bariatric surgeries grew by 113%. Our objective is to examine how 6-month complications improved between 2001 and 2006, using a nationwide, population-based sample. DATA/DESIGN: We examined insurance claims in 2001-2002 and 2005-2006 for 9582 bariatric surgeries, at 652 hospitals, among a population of 16…
Atomoxetine Use During a Period of FDA Actions
CONTEXT: The Food and Drug Administration (FDA) issued a Public Health Advisory entitled "Suicidal Thinking in Children and Adolescents Being Treated with Strattera (Atomoxetine)" on September 29, 2005. At FDA's request, the manufacturer subsequently added a boxed warning to the drug's labeling on November 8, 2005. OBJECTIVE: To evaluate whether the boxed warning for suicidal thinking in atomoxetine's labeling was associated with a change in the …
Medicine (2 works) · Atomoxetine (1 work) · Atomoxetine hydrochloride (1 work) · Attention Deficit Hyperactivity Disorder (1 work) · Bariatric Surgery and Outcomes (1 work) · Body Contouring and Surgery (1 work) · Complication (1 work) · Context (archaeology) (1 work) · Emergency Medicine (1 work) · Emergency Medicine (1 work)